Distinguished in Hyperparathyroidism

Ziad A. Massy

Boulogne-billancourt, FR 
Distinguished in Hyperparathyroidism
Boulogne-billancourt, FR 
OverviewLocationsClinical Research

Overview

Ziad Massy practices in Boulogne-billancourt, France. Mr. Massy is rated as a Distinguished expert by MediFind in the treatment of Hyperparathyroidism. His top areas of expertise are Calcinosis, Chronic Kidney Disease, Rickets, Kidney Transplant, and Nephrectomy.

His clinical research consists of co-authoring 472 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 17 articles in the study of Hyperparathyroidism.

Gender
Male

Locations

Boulogne-billancourt, France
Other Locations
Garches, 92380, France
Paris, France
Villejuif, 94076, France
CHRU de Nancy
Vandoeuvre-les-nancy, France
Bordeaux, France
CHU E Herriot
Lyon, 69003, France
Nancy, France
France
Saint-quentin-le-verger, France
CH du St Brieuc, St Brieuc
Sete, France
Saclay, France
Amiens, France
Versailles, France
Montigny-sur-loing, France
Pavillon Leriche 2è Étage CHU De Toulouse, Place Dr Baylac TSA40031, 31059 TOULOUSE Cedex 3, Toulouse, 31059, France
Lille, France
Verne, France
161, Rue De Sèvres 75015 Paris, Rouez, 75015, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase 3 Randomized, Open-label (Sponsor-blind), Active-controlled, Parallel-group, Multi-center, Event Driven Study in Non-dialysis Subjects With Anemia Associated With Chronic Kidney Disease to Evaluate the Safety and Efficacy of Daprodustat Compared to Darbepoetin Alfa
A Phase 3 Randomized, Open-label (Sponsor-blind), Active-controlled, Parallel-group, Multi-center, Event Driven Study in Non-dialysis Subjects With Anemia Associated With Chronic Kidney Disease to Evaluate the Safety and Efficacy of Daprodustat Compared to Darbepoetin Alfa
Enrollment Status: Completed
Publish Date: April 02, 2024
Intervention Type: Drug
Study Drugs: Daprodustat, Darbepoetin Alpha
Study Phase: Phase 3
Lung Water By Ultra-Sound Guided Treatment To Prevent Death and Cardiovascular Complications in High Risk End Stage Renal Disease Patients With Cardiomyopathy (Lust Study)
Lung Water By Ultra-Sound Guided Treatment To Prevent Death and Cardiovascular Complications in High Risk End Stage Renal Disease Patients With Cardiomyopathy (Lust Study)
Enrollment Status: Completed
Publish Date: March 14, 2023
Intervention Type: Other, Procedure
Study Phase: Not Applicable
View 1 Less Clinical Trial

472 Total Publications

A longitudinal analysis of haemoglobin levels and major cardiovascular events.
A longitudinal analysis of haemoglobin levels and major cardiovascular events.
Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
Published: November 09, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Massy's expertise for a condition
ConditionClose
View All 10 Advanced Conditions
View All 36 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile